#USA #Chicago #Reach3 Insights #Pharma Solutions #Patient Journey

Reach3 Insights Launches Revolutionary Pharma Solutions

In an impressive move to enhance pharmaceutical research, Reach3 Insights recently unveiled three innovative, AI-backed solutions targeted at Awareness, Trial and Usage (ATU), patient journeys, and communications research. This announcement took place on September 9, 2026, marking a significant step in integrating cutting-edge technology into healthcare research.

The new offerings capitalize on Reach3's mobile-first conversational research techniques, seamlessly combining predictive quantitative metrics with qualitative feedback through open-ended responses, images, and videos. This unified research framework is designed to provide a more holistic understanding of patient experiences and behaviors.

Overview of New Solutions

The three new solutions aim to enrich the existing methodologies in the pharma sector and include:

1. ATU: This framework supports brands both pre-launch and post-launch, delving deeper than traditional measures of awareness, trial, and usage. The focus is on uncovering the underlying perceptions, experiences, and behaviors of patients that drive awareness, adoption, and sustained usage.

2. Patient Journey: This solution crafts a detailed map of the patient experience, utilizing patients’ own words, images, and videos to pinpoint critical moments, barriers, and experiences along the care pathway. By anchoring insights in real patient narratives, it aims to shed light on the nuances that impact what patients encounter during their healthcare journey.

3. Communications: This aspect combines qualitative depth with quantitative scale to evaluate messages and campaigns, revealing what resonates with both patients and healthcare professionals. By sharing insights into why certain messages are compelling, this research can help shape more effective communication strategies.

Methodology and Impact

Reach3's comprehensive approach employs AI-powered moderation and probing, which enriches the depth of insights derived from participants. Furthermore, text message notifications facilitate timely follow-ups with patients and healthcare professionals, ensuring researchers can capture valuable feedback closely linked to specific experiences.

According to Amr Solouha, the healthcare practice lead at Reach3 Insights, “Some of the most useful context comes from hearing patients and HCPs describe an experience in their own words.” This commitment to understanding patient narratives aligns with Reach3's mission of creating authentic and impactful insights, which boost the decision-making processes of leading brands in the pharmaceutical industry.

In an event set for September 10, 2026, at 2 p.m. EDT, Reach3 Insights will further showcase these solutions during a webinar titled The Modern Pharma Insights Playbook: Re-imagining ATU, Patient Journeys, and Comms Testing in the AI Era, featuring industry giant Novartis. The session promises to explore exemplary case studies focusing on the application of momentary qualitative, quantitative, and video research methodologies in these domains.

About Reach3 Insights

Reach3 Insights stands as a full-service strategic consultancy recognized for its exemplary work in turning human behavior insights into actionable business strategies. The company employs AI-driven conversational methodologies to reveal the deeper emotions, contexts, and motivations fueling consumer behaviors, serving notable brands such as Novartis, Coca-Cola, and PayPal.

This forward-thinking approach to research positions Reach3 Insights at the forefront of the insights industry, allowing for the delivery of richer and more authentic data to guide brands towards informed, confident decisions. Part of the Rival Group, Reach3 Insights has been acknowledged as one of the top innovative full-service agencies in the 2025 GRIT report.

For more information about their offerings and insights, visit the official Reach3 Insights website.